Salarius Pharmaceuticals

SLRX59

Penny Stock

$1.82arrow_drop_down9.45%-$0.18

Penny Stock

SLRX59

$1.82

arrow_drop_down9.45%-$0.18

Penny Stock

Performance History

Key Stats
Open	$1.93
Prev. Close	$2.01
EPS	-8.73
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$2.89M
PE Ratio	-

	LOW	HIGH
Day Range	1.72	2.02
52 Week Range	1.32	7.44

Ratios

Revenue	-



EBITDA Margin %	-

EPS	-8.73

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Salarius Pharmaceuticals (SLRX)

Salarius Pharmaceuticals Inc (SLRX), a clinical-stage oncology company developing targeted therapies to treat solid tumors, has shown significant growth potential in the biotechnology sector. The company's stock price history reflects its upward trajectory, with consistent gains and minimal volatility. Investors have taken notice of Salarius Pharmaceuticals' promising prospects, driving up demand for its shares.

In recent news, Salarius Pharmaceuticals announced positive results from its phase 1/2 clinical trial for its lead drug candidate, Seclidemstat. The drug showed promising efficacy and safety profiles in patients with advanced solid tumors. This exciting development has sparked optimism among investors, leading to a surge in the company's stock price.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Mr. David J. Arthur M.B.A.
Headquarters: Houston
Employees: 12
Exchange: NASDAQ

add Salarius Pharmaceuticals to watchlist

Keep an eye on Salarius Pharmaceuticals

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Salarius Pharmaceuticals 's (SLRX) price per share?

The current price per share for Salarius Pharmaceuticals (SLRX) is $1.82. The stock has seen a price change of -$0.19 recently, indicating a -9.45% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Salarius Pharmaceuticals (SLRX)?

For Salarius Pharmaceuticals (SLRX), the 52-week high is $7.44, which is 308.79% from the current price. The 52-week low is $1.32, the current price is 37.88% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Salarius Pharmaceuticals (SLRX) a growth stock?

Salarius Pharmaceuticals (SLRX) has shown an average price growth of -2.03% over the past three years. It has received a score of 52 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Salarius Pharmaceuticals as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Salarius Pharmaceuticals (SLRX) stock price performance year to date (YTD)?

As of the latest data, Salarius Pharmaceuticals (SLRX) has a year-to-date price change of -64.46%. Over the past month, the stock has experienced a price change of 10.98%. Over the last three months, the change has been 18.18%. Over the past six months, the figure is -55.54%. Looking at a longer horizon, the five-year price change stands at -99.83%.

help

Is Salarius Pharmaceuticals (SLRX) a profitable company?

Salarius Pharmaceuticals (SLRX) has a net income of -$12.54M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$12.89K. Furthermore, the EBITDA is -$6.73M.

help

What is the market capitalization of Salarius Pharmaceuticals (SLRX)?

Salarius Pharmaceuticals (SLRX) has a market capitalization of $2.9M. The average daily trading volume is 1.83, indicating the stock's liquidity and investor engagement.